ClinicalTrials.Veeva

Menu

Impact of Sperm DNA Integrity on Artificial Reproductive Treatment (ART)

Northwell Health logo

Northwell Health

Status

Terminated

Conditions

Sperm DNA Impact on ART Outcomes

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT00875095
07.08.118

Details and patient eligibility

About

The purpose of this study is to establish a new criteria with which to judge the quality of sperm samples submitted for artificial reproductive treatments. It is believed that this type of testing can compliment the traditional semen analysis to better drive patient care.

Enrollment

8 patients

Sex

Male

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • needs interventions through artificial reproductive treatment to achieve a pregnancy

Exclusion criteria

  • severly oligozoospermic patients

Trial design

8 participants in 2 patient groups

IUI patients
Description:
Patients undergoing routine semen analysis as part of their infertility treatment pertaining to success or failure with intrauterine insemination, based upon their sperm DNA integrity
IVF patients
Description:
Couples undergoing routine screening prior to IVF retrievals to assess their reproductive treatment outcomes as compared to the sperm DNA integrity

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems